Autologous cell therapy
This page covers all Autologous cell therapy drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds.
Marketed (1)
- 3ml-Rejuvinex · Seoul National University Bundang Hospital · Regenerative Medicine
3ml-Rejuvinex is a regenerative medicine product designed to promote tissue repair and rejuvenation through cellular and growth factor delivery.
Phase 3 pipeline (8)
- ELIXCYTE · UnicoCell Biomed CO. LTD · Oncology
ELIXCYTE is an autologous cell therapy that expands and reinfuses a patient's own immune cells to enhance anti-tumor immunity. - CHONDRON · Sewon Cellontech Co., Ltd. · Orthopedics / Regenerative Medicine
CHONDRON is an autologous chondrocyte-based cell therapy that regenerates cartilage tissue by implanting a patient's own expanded cartilage cells into damaged joint areas. - NOVOCART® Inject plus · Tetec AG · Orthopedics / Rheumatology
NOVOCART® Inject plus is an autologous chondrocyte implantation therapy that delivers cultured patient cartilage cells directly into cartilage defects to promote tissue regeneration. - NOVOCART® 3D plus · Tetec AG · Orthopedics / Regenerative Medicine
NOVOCART® 3D plus is an autologous chondrocyte implant that regenerates cartilage tissue by delivering the patient's own expanded cartilage cells into a defect site. - Immuncell-LC · GC Cell Corporation · Oncology
Immuncell-LC is an autologous cell therapy that activates and expands a patient's own immune cells to enhance anti-tumor immunity. - REGENECYTE · StemCyte, Inc. · Regenerative Medicine
REGENECYTE is a cell therapy that uses expanded autologous bone marrow-derived stem cells to promote tissue regeneration and repair. - AMDC-USR (iltamiocel) · Cook MyoSite · Cardiovascular
AMDC-USR (iltamiocel) is an autologous skeletal myoblast cell therapy that regenerates damaged heart muscle tissue following myocardial infarction. - ChondroCelect implantation · TiGenix n.v. · Orthopedics / Rheumatology
ChondroCelect is an autologous cultured chondrocyte implant that replaces damaged cartilage by transplanting the patient's own expanded cartilage cells into the defect site.